162 related articles for article (PubMed ID: 29760569)
21. Prescribing practices of migraine-specific pharmacotherapy associated with emergency department use for migraine.
Cheng V; Billups SJ; Saseen JJ
Headache; 2021 Mar; 61(3):455-461. PubMed ID: 33377525
[TBL] [Abstract][Full Text] [Related]
22. High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.
Silva Almodóvar A; Nahata MC
J Am Geriatr Soc; 2023 Jan; 71(1):98-108. PubMed ID: 36289563
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications.
Kingsberg SA; McElroy SL; Clayton AH
Sex Med Rev; 2019 Jul; 7(3):380-392. PubMed ID: 30803922
[TBL] [Abstract][Full Text] [Related]
24. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.
Gerlach LB; Olfson M; Kales HC; Maust DT
J Am Geriatr Soc; 2017 Sep; 65(9):2052-2056. PubMed ID: 28467623
[TBL] [Abstract][Full Text] [Related]
25. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
Marcus SC; Shewale AR; Silberstein SD; Lipton RB; Young WB; Viswanathan HN; Doshi JA
Cephalalgia; 2020 Jun; 40(7):639-649. PubMed ID: 32223301
[TBL] [Abstract][Full Text] [Related]
26. The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.
Deighton AM; Harris LA; Johnston K; Hogan S; Quaranta LA; L'Italien G; Coric V
BMC Neurol; 2021 Nov; 21(1):425. PubMed ID: 34727873
[TBL] [Abstract][Full Text] [Related]
27. Opioid and Benzodiazepine Substitutes: Impact on Drug Overdose Mortality in Medicare Population.
Kuo YF; Liaw V; Yu X; Raji MA
Am J Med; 2022 Jul; 135(7):e194-e206. PubMed ID: 35341773
[TBL] [Abstract][Full Text] [Related]
28. Usage of triptans among migraine patients: an audit in nine GP practices.
Williams D; Cahill T; Dowson A; Fearon H; Lipscombe S; O'Sullivan E; Rees T; Strang C; Valori A; Watson D
Curr Med Res Opin; 2002; 18(1):1-9. PubMed ID: 11999139
[TBL] [Abstract][Full Text] [Related]
29. Current management of migraine in US emergency departments: an analysis of the National Hospital Ambulatory Medical Care Survey.
Friedman BW; West J; Vinson DR; Minen MT; Restivo A; Gallagher EJ
Cephalalgia; 2015 Apr; 35(4):301-9. PubMed ID: 24948146
[TBL] [Abstract][Full Text] [Related]
30. National Patterns of Medication Treatment for Depression, 1987 to 2001.
Stafford RS; MacDonald EA; Finkelstein SN
Prim Care Companion J Clin Psychiatry; 2001 Dec; 3(6):232-235. PubMed ID: 15014590
[TBL] [Abstract][Full Text] [Related]
31. SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
Hosenbocus S; Chahal R
J Can Acad Child Adolesc Psychiatry; 2011 Feb; 20(1):60-7. PubMed ID: 21286371
[TBL] [Abstract][Full Text] [Related]
32. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
33. Triptan medication use among patients with migraine with contraindications in the US.
Pero A; Pace A; Dhamoon MS
Headache; 2022 Jul; 62(7):883-889. PubMed ID: 35670141
[TBL] [Abstract][Full Text] [Related]
34. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects.
Baldo BA
Arch Toxicol; 2018 Aug; 92(8):2457-2473. PubMed ID: 29916050
[TBL] [Abstract][Full Text] [Related]
35. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
36. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF
Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
[TBL] [Abstract][Full Text] [Related]
37. Off-label prescribing patterns of antidepressants in children and adolescents.
Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
[TBL] [Abstract][Full Text] [Related]
38. Inappropriate medication prescribing for the elderly by office-based physicians.
Aparasu RR; Fliginger SE
Ann Pharmacother; 1997; 31(7-8):823-9. PubMed ID: 9220038
[TBL] [Abstract][Full Text] [Related]
39. Psychotropic prescribing for the elderly in office-based practice.
Aparasu RR; Mort JR; Sitzman S
Clin Ther; 1998; 20(3):603-16. PubMed ID: 9663374
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
